10-Hydroxyoleuropein



Compound IDCDAMM00930
Common name10-Hydroxyoleuropein
IUPAC namemethyl 4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-(2-hydroxyethylidene)-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
Molecular formulaC25H32O14

Experimental data

Retention time0.27
Adduct[M+Na]+
Actual mz579.168
Theoretical mz579.168
Error0.03
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.5663

Identifiers and class information

Inchi keyJCWFMPVGIIRRRG-IMYOZKAGNA-N
SmilesO=C(OC)C1=COC(OC2OC(CO)C(O)C(O)C2O)C(=CCO)C1CC(=O)OCCC3=CC=C(O)C(O)=C3
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)556.519
Computed dipole moment(dipole)4.539
Total solvent accessible surface area (SASA)860.235
Hydrophobic component of SASA (FOSA)355.646
Hydrophilic component of SASA (FISA)356.826
Pie component of the SASA (PISA)147.763
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1594.48
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)19.1
Free energy of solvation of dipole (dip^2/V)0.0129184
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0587442
Globularity descriptor (glob)0.767292
Predicted polarizability in cubic angstroms (QPpolrz)48.153
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.391
Predicted octanol/gas partition coefficient (QPlogPoct)37.124
Predicted water/gas partition coefficient (QPlogPw)30.537
Predicted octanol/water partition coefficient (QPlogPo/w)-1.394
Predicted aqueous solubility (QPlogS)-2.811
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.444
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.002
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4.094
Predicted brain/blood partition coefficient (QPlogBB)-4.502
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.298
Predicted skin permeability, log Kp (QPlogKp)-5.943
PM3 calculated ionization potential (IP(ev))9.016
PM3 calculated electron affinity (EA(eV))-0.063
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)-1.33
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)238.642
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P01112HRASTransforming protein p21/H-Ras-1T71081SEA
P60568IL2Interleukin-2T61698SwissTargetPrediction and SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P14679TYRTyrosinaseT97035SEA
P20916MAGMyelin-associated glycoprotein (by homology)T95286SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T95286DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P20916MAG

Copyright © 2025